Yuyu Pharma exceeds 50 million tablets collectively with Yuclid for the past 10 years
Yuyu Pharma(CEO In-Seok Choi) celebrated the 10-year anniversary of ‘Yuclid,’ a self-developed incrementally modified antiplatelet drug.
About 56,966,712 tablets or 661,750 units(30T, 300T) of Yuclid have been sold at the end of this May ever since its first launch on 1 September 2008. Since the...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
